Director/PDMR Shareholding

RNS Number : 2182C
Dechra Pharmaceuticals PLC
02 March 2011
 



Dechra Pharmaceuticals PLC 

("the Company")

 Directors / PDMR Share Dealing

 

2 March 2011

 

Dechra Pharmaceuticals PLC announces the following:

 

Exercise of LTIP options:

 

On 1 March 2011, the following Directors exercised options over ordinary shares of 1p each in the Company, granted to them on 29 February 2008 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP).  Each participant paid an exercise price of £1: 

 

Name

Capacity

Options Exercised

Shares Sold

Sale Price

per share

 

Total beneficial shareholding following this announcement

Percentage of issued share capital

Ian Page

Director

37,975

19,426

£5.0775

726,282

 

1.096%

Simon Evans

Director

22,152

0

0

882,689

1.332%

Edwin Torr

Director

20,253

10,361

£5.0775

411,381

0.621%

 

The exercise of the LTIP options were subject to the achievement of performance conditions which were satisfied in full.

 

All Directors (other than Simon Evans) have sold sufficient shares (acquired pursuant to the LTIP exercise) in order to fund the resulting tax liability.  

 

 

For further information

 

Zoe Goulding, Company Secretary            

Telephone number: 01782 771100

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDKBDPPBKDDNK
UK 100

Latest directors dealings